7-(4-Biphenyloxy)heptanoic acid | 139475-43-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 7-(4-Biphenyloxy)heptanoic acid
• 英文别名: 7-([1,1'-biphenyl]-4-yloxy)heptanoic acid；7-(4-phenylphenoxy)heptanoic acid
• CAS: 139475-43-7
• 化学式: C₁₉H₂₂O₃
• 分子量: 298.382
• InChiKey: FLZBULNERNNDPR-UHFFFAOYSA-N

物化性质

• 沸点：
  490.2±38.0 °C(Predicted)
• 密度：
  1.095±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.6
• 重原子数：
  22
• 可旋转键数：
  9
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.32
• 拓扑面积：
  46.5
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  7-(4-Biphenyloxy)heptanoic acid 在 氯化亚砜 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 以94%的产率得到7-(Biphenyl-4-yloxy)-heptanoyl chloride
  参考文献：
  名称：

  Heterocyclic ketones as inhibitors of histone deacetylase

  摘要：

  Several heterocyclic ketones were investigated as potential inhibitors of histone deacetylase. Nanomolar inhibitors such as 22 and 25 were obtained, the anti-proliferative activity of which were shown to be mediated by HDAC inhibition. (C) 2003 Published by Elsevier Ltd.

  DOI：

  10.1016/j.bmcl.2003.09.007
• 作为产物：
  描述：

  7-溴庚酸甲酯 在 lithium hydroxide 、 caesium carbonate 作用下， 以 四氢呋喃 、 N,N-二甲基甲酰胺 为溶剂， 生成 7-(4-Biphenyloxy)heptanoic acid
  参考文献：
  名称：

  Heterocyclic ketones as inhibitors of histone deacetylase

  摘要：

  Several heterocyclic ketones were investigated as potential inhibitors of histone deacetylase. Nanomolar inhibitors such as 22 and 25 were obtained, the anti-proliferative activity of which were shown to be mediated by HDAC inhibition. (C) 2003 Published by Elsevier Ltd.

  DOI：

  10.1016/j.bmcl.2003.09.007

文献信息

• Inhibitors of histone deacetylase
  申请人：——

  公开号：US20020177594A1

  公开（公告）日：2002-11-28

  Compounds having the formula 1 or therapeutically acceptable salts thereof, are histone deacetylase (HDAC) inhibitors. Preparation of the compounds, compositions containing the compounds, and treatment of diseases using the compounds are disclosed.

  具有以下化学式的化合物或其治疗上可接受的盐是组蛋白去乙酰化酶（HDAC）抑制剂。本文揭示了该化合物的制备、含有该化合物的组合物以及使用该化合物治疗疾病的方法。
• Substituted hydroxyureas
  申请人：Ortho Pharmaceutical Corporation

  公开号：US05066658A1

  公开（公告）日：1991-11-19

  The present invention relates to substituted hydroxyureas. These compounds inhibit the enzyme 5-lipoxygenase. In addition, certain of the compounds also inhibit the enzyme-cyclooxygenase. The compounds are useful for treating asthma, allergies, arthritis, posoriasis, ischemia, dermatitis, inflammation and/or broncho-constriction and/or inflammatory diseases of the eye.

  本发明涉及取代羟基脲。这些化合物抑制酶5-脂氧化酶。此外，某些化合物还抑制酶环氧合酶。这些化合物可用于治疗哮喘、过敏、关节炎、银屑病、缺血、皮炎、炎症和/或支气管收缩和/或眼部炎症性疾病。
• Inhibitors of Histone Deacetylase
  申请人：Delorme Daniel

  公开号：US20090181971A1

  公开（公告）日：2009-07-16

  The invention relates to the inhibition of histone deacetylase. The invention provides compounds and methods for inhibiting histone deacetylase enzymatic activity. The invention also provides compositions and methods for treating cell proliferative diseases and conditions.

  本发明涉及抑制组蛋白去乙酰化酶的技术。本发明提供了抑制组蛋白去乙酰化酶酶活性的化合物和方法。本发明还提供了治疗细胞增殖性疾病和病状的组合物和方法。
• INHIBITORS OF HISTONE DEACETYLASE
  申请人：Methylgene, Inc.

  公开号：EP1280764A2

  公开（公告）日：2003-02-05
• COMPOSITION, FILM AND LIQUID CRYSTAL DISPLAY
  申请人：Okazaki Masaki

  公开号：US20090130344A1

  公开（公告）日：2009-05-21

  A novel composition is disclosed. The composition comprises, at least, a polymer material and inorganic fine particles having adsorbed thereto molecules having at least one adsorptive group to the inorganic fine particle and a group capable of forming a liquid crystal core. A film made of the composition is also disclosed.